BTI
NUVB icon

Blue Trust Inc’s Nuvation Bio NUVB Stock Holding History

Blue Trust Inc’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,474
Closed -$5K – 2550
2023
Q4 		$5K Buy
+3,474
New +$4.47K ﹤0.01% 1856
2023
Q2 		– Sell
-152
Closed – – 2367
2023
Q1 		$0 Buy
152
+80
+111% +$162 ﹤0.01% 2530
2022
Q4 		$0 Buy
72
+38
+112% +$77 ﹤0.01% 2390
2022
Q3 		$0 Buy
+34
New +$97 ﹤0.01% 2247

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Blue Trust Inc's NUVB Position: Q1 2024 in Review

Blue Trust Inc sold out of Nuvation Bio (NUVB) in Q1 2024, closing a stake of 3,474 shares — an estimated $5K sold.

Blue Trust Inc first reported a position in NUVB in Q3 2022 and held it in 4 quarters. The position peaked at $5K in Q4 2023. 124 funds tracked by Wall St. Rank hold NUVB as of Q1 2024.

  • Blue Trust Inc reported no remaining Nuvation Bio position as of Q1 2024 after selling out during the quarter.
  • Blue Trust Inc sold 3,474 Nuvation Bio shares in Q1 2024, an estimated $5K.
  • Blue Trust Inc first reported a position in Nuvation Bio in Q3 2022 and held it in 4 quarters.
  • Blue Trust Inc's Nuvation Bio position peaked at $5K in Q4 2023.
  • 124 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2024.

Based on Blue Trust Inc's 13F filing for Q1 2024, filed 1 May 2024.